c o m
Necrotizing fasciitis is a pathological descriptive term applied to a life-threatening soft-tissue infection. Previous synonyms of necrotizing fasciitis were hospital gangrene, suppurative fasciitis and Fournier's gangrene. [1] Necrotizing fasciitis is an uncommon, potentially life-threatening infection that involves soft tissue and causes progressive destruction of fascia and adipose tissue. Because of its rapid progression and high mortality, it continues to be a dire emergency as it was when Meleney Þ rst described the disease in 1924 in China.
[2] These patients usually have comorbid diseases that cause immunocompromised status in affected patients. Diabetic patients have an increased propensity to develop soft-tissue infections. Recent review of necrotizing fasciitis showed up to 25% of the cases had diabetes mellitus as a comorbid disease.
[3] The purpose of the present study was to analyze association of diabetes mellitus with necrotizing fasciitis and to study presentation; type of infection; surgical, medical management; and outcome of this uncommon surgical emergency.
Methodology
Hamad Medical Corporation is a 1,444-bedded tertiary medical care center with 12-bedded surgical intensive care unit (SICU). Medical records of patients treated with necrotizing fasciitis at our SICU between January 1995 and February 2005 were retrospectively reviewed. Only those patients with diagnosis confirmed by histopathology were included in the study.
The variables that were examined, documented and analyzed in this study included age, gender, location 
Results
Ninety-four patients with necrotizing fasciitis were treated at our SICU during the period under review, which accounts for 1.15% of total admission to the SICU. Diabetes mellitus was a comorbid disease in 56.4% of the patients. Diabetic patients and necrotizing patients were signiÞ cantly older (55 years) compared to nondiabetic patients (40.2 years); 75.5% of patients were male and 24.5% were female. Of the predisposing factors, 11.7% had history of operation, 10.6% had history of trauma, 2.1% of cases had history of insect bite. As many as 48.9% of the patients had history of taking nonsteroidal anti-inflammatory drugs (NSAID). There was signiÞ cant difference regarding the type of necrotizing fasciitis that both groups had; diabetic patients had type 1 necrotizing fasciitis more commonly (71.7%), while nondiabetic patients had type 2 necrotizing fasciitis (64.4%) [ Table 1 ].
Patients of both groups had fever and leukocytosis on admission to the hospital [ Table 2 ]. All the patients in both groups underwent surgical debridement twice. The mean SOFA score in diabetic patients was 8.6, whereas it was 8.5 in nondiabetic patients. Diabetic group received total ß uid, 4.7 ± 2.1 liters; packed red blood cells (PRBC), 1.9 ± 1.9 units; fresh frozen plasma (FFP), 3.6 ± 3.8 units; platelet concentrate, 1.0 ± 4.1 units; while nondiabetic group patients received ß uid, 5.0 ± 2.2 liters; PRBC, 2.2 ± 2.5 units; FFP, 4.2 ± 4.6 units; platelet concentrate, 2.4 ± 5.8 units in the Þ rst 24 h of admission to the SICU.
Intubation days and ICU stay in diabetic group were 3.8 ± 3.5 and 5.9 ± 5.5 days respectively; while in the nondiabetic group, these were 6.2 ± 7.2 and 9.8 ± 12.9 days respectively. There was no signiÞ cant difference in above variables in the two groups. Figure 1 shows location of necrotizing fasciitis in both groups. In the diabetes group a significantly high number of patients had necrotizing fasciitis of perineum and genitalia (30.2%); while in the nondiabetic group, a signiÞ cantly high number of necrotizing fasciitis of leg and foot was observed.
Figure 2 shows microbiological characteristic of these groups. E. coli was the most common bacterium isolated from the necrotic tissue in diabetic patients; but in the nondiabetic group, streptococci were the most common bacteria. This difference was statistically signiÞ cant.
As many as 46.8% of the patients had multi-organ dysfunction syndrome [MODS] . Overall mortality was 16% (diabetic group, 15.1%; and nondiabetic group, 17.1%). The difference in mortality between the two groups was statistically insigniÞ cant.
Discussion
The 'soft-tissue infections' is a difficult-to-handle subject because of the complicated nature of these infections and lack of universal and useful terminology Shaikh: Necrotizing fasciitis and diabetes mellitus to describe them. The term 'necrotizing fasciitis' represents a continuum of an uncommon infection of subcutaneous tissue that progressively spreads along fascial plans. Necrotizing fasciitis is a surgical and medical emergency. It is more common in males than in females.
[4] Necrotizing fasciitis can affect any age group, but the age of diabetic patients having the disease was higher; in a large study, the mean age of these patients was 55 years. [5] This study also showed that diabetic patients were signiÞ cantly older. Necrotizing fasciitis usually had some predisposing factors, such as trauma, surgery, insect bite and scratch. [6] Necrotizing fasciitis patients have a pre-existing disease that renders them susceptible to infections and immunocompromised status, such as old age, chronic renal failure, diabetes mellitus and drug misuse. [7] Diabetes mellitus is blamed to be commonly associated with necrotizing fasciitis. Higher blood sugar in these patients produces a good medium for bacterial growth and predisposes to an environment of low oxygen tension and rich substrate for bacterial growth. [8] Diabetes mellitus was the comorbid condition in 40-60% of cases with Fournier's gangrene patients.
[9] In our study, diabetes mellitus was the comorbid condition in 56.4% of the cases.
In this study, diabetic patients had signiÞ cantly higher incidence of type 1 necrotizing fasciitis, and literature also conÞ rms that type 1 necrotizing fasciitis is common in diabetes mellitus patients.
[10] E. coli was the most common bacterium isolated from necrotic tissue of diabetic patients. Sharp et al. demonstrated that E. coli was one of the four common organisms isolated from Shaikh: Necrotizing fasciitis and diabetes mellitus type 1 necrotizing fasciitis patients.
[11]
Common area affected by necrotizing fasciitis in diabetic patients was perineum; and in nondiabetic patients, it was extremities. All our patients had fever and leukocytosis at admission to the hospital; these were systemic manifestations of the disease, recently published LRINEC (laboratory risk indicators for necrotizing fasciitis) score leukocytosis is one of the indicators by which we can diagnose the disease early and differentiate necrotizing fasciitis from other softtissue infections. [12] Aggressive surgical debridement and aggressive ß uid resuscitation are the cornerstones of management of this disease. Each of our patients underwent surgical debridement at least two times.
Mean SOFA score in both groups of patients was more than 8, which indicates severity of the disease, need for intensive care admission and aggressive resuscitation. [13] Necrotizing fasciitis patients need aggressive ß uid and electrolyte therapy and hemodynamic stabilization. Large volume of extracellular ß uid may be sequestered in the edematous wound, requiring large volumes of ß uids. Hemolysis and coagulation disorders require blood and blood products. [14] Both group patients received more the 4 liters of ß uid, 2 units PRBC, 3 units FFP during the initial 24 h [ Table 2 ].
Necrotizing fasciitis was associated with high mortality and morbidity -46.8% of our patients had multipleorgan dysfunction; overall mortality was 16%. The reported mortality in literature varies from 6 to 76%. [15] There was no signiÞ cant difference in mortality between diabetic and nondiabetic patients, although it is often remarked that mortality is increased in the presence of diabetes mellitus, which is not always the case.
Conclusion
Diabetes mellitus is a common comorbid disease associated with necrotizing fasciitis. In this study, diabetic patients were signiÞ cantly older and suffered from type 1 necrotizing fasciitis of the perineum. There was no difference in mortality between diabetic and nondiabetic patients.
